PATENT CLAIM ANALYSIS

Application Number: 16390175
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["514", "275000"]

Abstract:
The invention provides a compound of formula (I): or a pharmaceutically-acceptable salt thereof, that is an inhibitor of JAK kinases. The invention also provides pharmaceutical compositions comprising such compound, a crystalline form, methods of using such compound to treat inflammatory skin diseases and other diseases, and processes and intermediates useful for preparing such compound.

Claim (Index 50):
The method of  claim 44 , wherein compound (I), or a pharmaceutically acceptable salt thereof, is present at between 0.05 and 0.5% by weight.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 100.0
- Lexical Diversity: 1.43182
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16171693', '16050227', '15498803', '15435735', '15966467']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6561949583494464
- 35 USC 102 Novelty (BERT): 0.5247636965609951
- Combined Prediction Score: 0.6430518321706012
- Mean Citation Score: 240.7330440000001
- Max Citation Score: 309.1548
- Similarity Product: 212.92295123898984

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test